The percentage of apoptosis in cisplatin treated cells was found to be 37.95% as compared to a very low percentage of apoptotic cells in the untreated PKCδ deficient B16F10 melanoma cells (Figure 1E). The gene discussed is PRKCD; the disease is melanoma.